Patterns of collaboration along the bio-pharmaceutical innovation process

Patterns of collaboration along the bio-pharmaceutical innovation process

Vorheriger Titel:	Patterns of collaboration along the bio-pharmaceutical innovation process
Verfasser:	Chiaroni, Davide Chiesa, Vittorio ^GND Frattini, Federico ^GND ^ORCID ^VIAF
FB/Einrichtung:	FB 12: Chemie und Pharmazie
Dokumenttypen:	Artikel
Medientypen:	Text
Erscheinungsdatum:	2008
Publikation in MIAMI:	28.09.2022
Datum der letzten Änderung:	30.09.2022
Quelle:	Journal of Business Chemistry, 5 (2008) 1, S. 7-22
Angaben zur Ausgabe:	[Electronic ed.]
Fachgebiet (DDC):	330: Wirtschaft
Lizenz:	InC 1.0
Sprache:	English
Anmerkungen:	Section "Research Section"
Format:	PDF-Dokument
URN:	urn:nbn:de:hbz:6-52069670808
Weitere Identifikatoren:	DOI: 10.17879/52069670253
Permalink:	https://nbn-resolving.de/urn:nbn:de:hbz:6-52069670808
Onlinezugriff:	2008_vol5_iss1_7-22.pdf

Journal of Business Chemistry

1 (2004) 1, S. 2-13: Enhancing market-oriented R&D planning by integrated market and patent portfoli...
1 (2004) 1, S. 14-20: Intellectual capital and competitive advantages the case of TTY Biopharm Compa...
1 (2004) 1, S. 21-24: Accelerating the processes of innovation Degussa's new bonus system creates in...
1 (2004) 2, S. 22-36: Organising product stewardship in large chemical companies
1 (2004) 2, S. 37-47: Virtual communities as an organizational mechanism for embedding knowledge in ...
1 (2004) 2, S. 48-53: The human side of innovation
2 (2005) 1, S. 1-3: Why are scientists not managers!? the importance of interdisciplinary skills in ...
2 (2005) 1, S. 4-18: Condiment paprika research in Australia
2 (2005) 1, S. 19-36: Chemicals regulation and the Porter Hypothesis a critical review of the new Eu...
2 (2005) 1, S. 37-53: Futuring in the European chemical industry
2 (2005) 2, S. 54: Defining "Business Chemistry"
2 (2005) 2, S. 55-70: Internationalisation of SMEs a micro-economic approach
2 (2005) 2, S. 71-89: "Sensory Fit Panel" – Development of a new Advertising Claim Support method ...
2 (2005) 2, S. 90-96: High-Performance research for High-tech materials 1. Degussa’s Science-to-Bu...
2 (2005) 3, S. 97-98: Trends in biotechnology opportunities and threats for developing countries!?
2 (2005) 3, S. 99-106: Different rhythms of health biotechnology development in Brazil and Cuba
2 (2005) 3, S. 107-111: Streptomyces as a host for the secretion of heterologous proteins for the pr...
2 (2005) 3, S. 112-118: Science and society in Cuba in the context of techno-economic globalization
2 (2005) 3, S. 119-125: Propolis patents and technology trends for health applications
2 (2005) 3, S. 126-137: Future studies in Brazil CGEE approach for bio- and nanotechnology
3 (2006) 1, S. 1: End of an Era? the chemical industries’ future
3 (2006) 1, S. 2-12: The global business of chemistry prospects and challenges
3 (2006) 1, S. 13-21: Systematically creating coincidental product evolution case studies of the app...
3 (2006) 1, S. 22-41: The consumption of Sicilian red oranges implications for firms involved in com...
3 (2006) 1, S. 42-48: Intellectual property an underestimated and undermanaged asset?
3 (2006) 2, S. 1: Interdisciplinarity at Work
3 (2006) 2, S. 3-5: School for the bilingual dual master’s degrees in business and biotech
3 (2006) 2, S. 7-14: How do Italian biotechnology startups survive?
3 (2006) 2, S. 15-30: Detergent phosphates an EU policy assessment
3 (2006) 2, S. 31-38: Chemische Fabrik Griesheim – pioneer of electrochemistry
3 (2006) 3, S. 1: Changes in the chemical industry
3 (2006) 3, S. 3-8: Dialogue on nanotech the South Carolina Citizens’ School of Nanotechnology
3 (2006) 3, S. 9-25: Innovation strategies for the Australian chemical industry
3 (2006) 3, S. 27-41: Three-dimensional valuation of IP rights
3 (2006) 3, S. 43-47: The future belongs to renewable resources
4 (2007) 1, S. 1: Struggling for profitability not necessarily new, but challenging
4 (2007) 1, S. 3-10: Commentary CeNTech nanotechnological research and application
4 (2007) 1, S. 11-19: Open innovation the new way of knowledge transfer?
4 (2007) 1, S. 21-32: A model of knowledge sharing in biomedical engineering challenges and requirem...
4 (2007) 1, S. 33-39: Value pricing in the chemical industry most powerful lever to profitability
4 (2007) 2, S. 40: Tackling present and future challenges of the chemical industry
4 (2007) 2, S. 42-44: Australian cooperative business
4 (2007) 2, S. 46-58: Knowledge management and knowledge-based marketing
4 (2007) 2, S. 60-75: Engineering an instrument to evaluate safety critical manning arrangements in ...
4 (2007) 2, S. 76-86: Technology to clean up coal for the post-oil era
4 (2007) 3, S. 88: Exploring the wide field of business chemistry
4 (2007) 3, S. 90-95: Channel management in the chemical industry selecting the right option
4 (2007) 3, S. 96-114: Testing costs and testing capacity according to the REACH requirements result...
4 (2007) 3, S. 116-126: Enthalpy change firing enthusiasm for learning
4 (2007) 3, S. 128-136: Chemical plant engineering projects customers around the world prefer cuttin...
5 (2008) 1, S. 1-3: The Journal of Business Chemistry five issues of covering the latest trends in r...
5 (2008) 1, S. 5-6: REACh a European chemicals regulation with global intersectoral consequences
5 (2008) 1, S. 7-22: Patterns of collaboration along the bio-pharmaceutical innovation process
5 (2008) 1, S. 23-38: The spatial dynamics of the European biotech industry a NEG approach with vert...
5 (2008) 1, S. 39-43: The growing importance of covering payment risks in the chemical industry
5 (2008) 2, S. 44: Developments at the outposts of the chemical industry
5 (2008) 2, S. 46-47: REACh due diligence – Extended scope of M&A services in the framework of REA...
5 (2008) 2, S. 48-63: Entrepreneurial potential in chemistry and pharmacy results from a large surve...
5 (2008) 2, S. 64-68: A motor for future-proof jobs the results of the study "Biotechnology in Germa...
5 (2008) 2, S. 70-78: Unbiased insight on biopharma’s innovation crisis
5 (2008) 3, S. 79: Dark clouds are gathering
5 (2008) 3, S. 81-82: Sector inquiry into the pharmaceutical sector
5 (2008) 3, S. 83-93: The value based portfoliomanagement in response to REACh a manual of different...
5 (2008) 3, S. 101-105: Managing the effects of the business cycle in the chemical industry
6 (2009) 1, S. 1-2: Discussing challenges in the chemical industry for five years
6 (2009) 1, S. 3-6: The effects of the financial crisis on the future of the chemical industry
6 (2009) 1, S. 7-9: Mergers & Acquisitions (M&A) in the Pharmaceutical and Chemical Industries: A Li...
6 (2009) 1, S. 11-30: Open source biopharmaceutical innovation a mode of entry for firms in emerging...
6 (2009) 1, S. 31-41: Biotechnology research in South Africa a benchmarking exercise
6 (2009) 1, S. 43-54: REACH effects – opportunities and risks for transfer pricing
6 (2009) 2, S. 55-56: Thunderstorms strike the economy
6 (2009) 2, S. 57-63: The place of chemistry in business
6 (2009) 2, S. 65-67: Chemists of the future
6 (2009) 2, S. 69-87: REACH and the role of stakeholders in its socio-economic analysis
6 (2009) 2, S. 89-96: Patent license negotiation best practices
6 (2009) 2, S. 97-105: M&A since Y2K - an overview of chemicals deals invilving BRIC countries in th...
6 (2009) 3, S. 106: Preparing for the time after the crisis
6 (2009) 3, S. 108-110: A capital market's view on Industrial Biotechnology proper valuation is the ...
6 (2009) 3, S. 112-125: Assessment of thermal-stable polymer nanocomposite techniques by patent cita...
6 (2009) 3, S. 126-136: Feasibility of Active Ingredient (AI) development for new biocides in the EU
6 (2009) 3, S. 138-146: How to implement ‘access to medicine’ AND enhance economic performance b...
7 (2010) 1, S. 1: Tiny things being huge
7 (2010) 1, S. 3-13: Nanotechnology patenting in China and Germany a comparison of patent landscapes...
7 (2010) 1, S. 15-30: Identifiyng the emerging roles of nanoparticles in biosensors
7 (2010) 1, S. 31-45: Knowledge sharing in heterogeneous collaborations a longitudinal investigation...
7 (2010) 2, S. 67-68: Mergers & acquisitions (M&A) in the pharmaceutical industry the wheel keeps on...
7 (2010) 2, S. 69-79: New biocide active substances needs and challenges in the EU as viewed by indu...
7 (2010) 2, S. 81-88: REACH implementation costs in the Belgian food industry a semi-qualitative stu...
7 (2010) 2, S. 89-96: Performance improvement in pharmaceutical R&D through new outsourcing models
7 (2010) 2, S. 97-106: Sustainability in the chemical and pharmaceutical industry results of a bench...
7 (2010) 3, S. 109-115: Bio products from bio refineries trends, challenges and opportunities
7 (2010) 3, S. 117-130: Analyzing the Direct Methanol Fuel Cell technology in portable applications ...
7 (2010) 3, S. 131-153: Multidisciplinary collaborations in pharmaceutical innovation a two case-stu...
7 (2010) 3, S. 155-163: Pharma 3.0 delivering on health outcomes
8 (2011) 1, S. 3-4: Industrial biotechnology becomes a key competitive factor
8 (2011) 1, S. 5-16: Towards a phenotype of the amphibious company an illustrative case from the che...
8 (2011) 1, S. 17-33: Exploring market knowledge in product development of chemical firms
8 (2011) 1, S. 35-45: Pricing in the crisis? an empirical analysis
8 (2011) 2, S. 49-63: Optimal ambidexterity and exploration valuableness balancing short-term and lo...
8 (2011) 2, S. 65-74: The challenges and opportunities of the European Union leadmarket initiative c...
8 (2011) 2, S. 75-86: Sources of information for technology intelligence in chemical formulation
8 (2011) 2, S. 87-98: Working capital management in the Swiss chemical industry
8 (2011) 3, S. 101-113: R&D Spin-outs in the pharmaceutical industry
8 (2011) 3, S. 115-122: Supply-side determinants of Energy Consumption and Efficiency (ECE) innovati...
8 (2011) 3, S. 123-132: Procurement in 21st century in the chemical, pharmaceutical and healthcare i...
8 (2011) 3, S. 133-146: Application of timing option to founding investment decision of biotech star...
9 (2012) 1, S. 3-18: Startup of new plants and process technology in the process industries organizi...
9 (2012) 1, S. 19-30: The founding angels investment model case studies from the field of nanotechno...
9 (2012) 1, S. 31-48: Standardized cost estimation for new technologies (SCENT) methodology and tool
9 (2012) 1, S. 49-62: Development of an effective outsourcing strategy for toxicological studies in ...
9 (2012) 2, S. 65-66: The future of chemical distribution in Europe customer relations as key value ...
9 (2012) 2, S. 67-84: Collaborative development of new process technology/equipment in the process i...
9 (2012) 2, S. 85-104: Opportunities for- and configuration of foreign innovation a case study of mu...
9 (2012) 2, S. 105-113: Chemical distribution in Belgium from 2007 to 2010 an empirical study
9 (2012) 3, S. 117-131: Open innovation and firm performance in small-sized R&D active companies in ...
9 (2012) 3, S. 133-146: Research inequality in nanomedicine
9 (2012) 3, S. 147-160: Morphological Analysis of technologies using multidimensional scaling
9 (2012) 3, S. 161-166: IP strategies in business operations with China
10 (2013) 1, S. 3-21: Management of technology licensing as a foreign market entry mode the case of ...
10 (2013) 1, S. 23-34: The influence of the global crisis on the management of the small firms activ...
10 (2013) 1, S. 35-48: Development of integrated production networks using extended material flow an...
10 (2013) 1, S. 49-56: Personalised medicine, unmet need or business strategy?
10 (2013) 2, S. 59-66: Challenges and strategies for chemical/industrial parks in Europe
10 (2013) 2, S. 67-87: Inter-industry innovations in terms of electric mobility Should firms take a ...
10 (2013) 2, S. 89-98: Are you still comparing or already learning? experience report of a Facility ...
10 (2013) 2, S. 99-111: How to secure sustainable competitiveness of Chemical Industry Parks global ...
10 (2013) 3, S. 115-130: Technology transfer by new ventures within the chemical and pharmaceutical ...
10 (2013) 3, S. 131-137: LEAN SCM a paradigm shift in supply chain management
10 (2013) 3, S. 139-149: Optimization of economic conditions in the chemical, pharmaceutical and med...
10 (2013) 3, S. 151-160: Classification of chemicals in the commercial area
11 (2014) 1, S. 3-13: Hidden markets in the chemical industry illusion or growth opportunity?
11 (2014) 1, S. 15-32: Proactive R&D management and information disclosure ramifications for innovat...
11 (2014) 1, S. 33-42: Improving R&D productivity requires a balanced approach
11 (2014) 1, S. 43-50: Bioplastics tipping point drop-in or non-drop-in?
11 (2014) 2, S. 53-66: Impacts of the REACH candidate list of substances subject to authorisation th...
11 (2014) 2, S. 67-76: Practitioner’s Section: Integrated Resource Efficiency Analysis for Reducin...
11 (2014) 2, S. 77-86: Account management 2.0 from silo thinking to integrated account development
11 (2014) 2, S. 87-97: On the current practice of New Business Development in the German chemical in...
12 (2015) 1, S. 3-15: Nanotechnology companies in the United States a web-based content analysis of ...
12 (2015) 1, S. 17-30: Supply Value Management A benchmarking study and a new theoretical approach s...
12 (2015) 1, S. 31-37: Chemical industry activity as a leading indicator of the business cycle
12 (2015) 2, S. 39: 11th anniversary of the Journal of Business Chemistry
12 (2015) 2, S. 41-47: From megatrends to business excellence Managing change in the German chemical...
12 (2015) 2, S. 49-53: Can a top-executive in the chemical industry “survive” without a Business...
12 (2015) 2, S. 55-65: Size does matter in chemical distribution
12 (2015) 3, S. 69-84: Factors influencing organizational change and health evidences from the India...
12 (2015) 3, S. 85-103: The benefits of social sustainability reporting for companies and stakeholde...
12 (2015) 3, S. 105-124: Biomedical research and development in the Indian therapeutic drug industry
12 (2015) 3, S. 117-124: Managing risk during turnarounds and large capital projects experience from...
13 (2016) 1, S. 3-16: Are behavioral pricing tactics also present in the B2B context? evidence from ...
13 (2016) 1, S. 17-32: Critical challenges for SMEs in the UK chemical distribution industry
13 (2016) 1, S. 33-46: Understanding the market dynamics of biosimilars
13 (2016) 1, S. 47-58: PhytoGerm: extraction of germanium from biomass an economic pre-feasibility s...
13 (2016) 2, S. 60-63: Fostering start-ups in the chemical sector through the joint support offered ...
13 (2016) 2, S. 64-79: From customer understanding to product understanding: Collaboration with indu...
13 (2016) 2, S. 80-92: The logistics profile of the German chemical industry
13 (2016) 3, S. 94-98: The focus of the Journal of Business Chemistry: Good management practices in ...
13 (2016) 3, S. 99-101: Managing growth and profitability in the chemical industry Interview with Ha...
13 (2016) 3, S. 102-113: High speed development of new chemical synthesis and materials at molecular...
14 (2017) 1, S. 2-10: Novel approaches in professional education to foster innovation in the chemica...
14 (2017) 1, S. 11-21: The future of German chemical sites: Potential pathways and organizational re...
14 (2017) 1, S. 22-24: Successful management of chemical sites: A challenge for management theory an...
14 (2017) 2, S. 26-28: Digitalization of the chemical industry
14 (2017) 2, S. 29-40: Marketing of chemical parks: Challenges and perspectives
14 (2017) 2, S. 41-50: Design thinking as driver for innovation in the chemical industry
14 (2017) 2, S. 51-64: Implementation of Open Innovation in Chemical B2B Companies
14 (2017) 3, S. 66-72: Brexit and the UK chemical supply chain A commentary on potential effects
14 (2017) 3, S. 73-78: Value pricing in the chemical industry – Rebooted
14 (2017) 3, S. 79-93: Raw Material Excellence in the chemical industry, a game changer turning cost...
14 (2017) 3, S. 94-105: Digitalization in the process industries – Evidence from the German water ...
14 (2017) 3, S. 106-121: Mercury Free UV Lamp for Disinfection and Purification of Drinking, Process...
15 (2018) 1: The road ahead: Digitalization fuels innovation
15 (2018) 1: Business Chemistry: The successful establishment of an interdisciplinary field
15 (2018) 1: Quo vadis Business Chemistry?
15 (2018) 1: Motivation for Innovations - Experiences and Reflections
15 (2018) 1: Chemistry 4.0 - Growth through innovation in a transforming world
15 (2018) 1: Re-inventing chemistry – an industry in transition
15 (2018) 2, S. 56-62: Digitalization, chemical distribution and the chemical value chain
15 (2018) 2, S. 63-70: The digitalization of marketing and sales in the chemical B2B sector
15 (2018) 2, S. 71-77: Successful data applications a cross-industry approach for conceptual plannin...
15 (2018) 2, S. 78-92: Quantitative biology – a perspective for the life sciences' way into the fu...
15 (2018) 3, S. 94-95: Specialty chemicals and contending with forces of change
15 (2018) 3, S. 96-106: Impact of tightened environmental regulation on China´s chemical industry
15 (2018) 3, S. 107-112: The need for diversity in the chemical industry
16 (2019) 1, S. 2-10: The long term survival through innovation
16 (2019) 1, S. 11-25: Managing business model innovation for relocalization in the process and manu...
16 (2019) 1, S. 41-53: Artificial Intelligence in the process industries – technology overview, ca...
16 (2019) 1, S. 54-72: Collaboration in the context of industry convergence - an overview
16 (2019) 1, S. 58-72: Implementation of sustainability in innovation management: The Idea to People...
16 (2019) 2, S. 74-75: Lessons from "Goodbye Hoechst"
16 (2019) 2, S. 76-81: The Digital Revolution is coming to chemical laboratories
16 (2019) 2, S. 82-90: The relation of energy value chains, global GDP and CO2 taxes
16 (2019) 2, S. 91-105: How digital tools make circular economy operational in industrial areas: The...
16 (2019) 2, S. 106-122: Challenges and opportunities in the sustainability of communication devices...
16 (2019) 2, S. 123-133: The smart-up ecosystem: Turning Open Innovation into smart business
16 (2019) 2, S. 134-147: Managing product variety under operational constraints: A process-industria...
16 (2019) 3, S. 149-153: A pulse on the specialty chemical sector
16 (2019) 3, S. 154-164: Challenges affecting the adoption of B2B electronic marketplaces
16 (2019) 3, S. 165-179: A holistic framework and development agenda for accelerated transition towa...
16 (2019) 3, S. 180-197: Commodity price fluctuations and the EROI of oil - How the availability of ...
17 (2020) 1, S. 2-8: Can an artificial intelligence model be the inventor of a molecule designed by ...
17 (2020) 1, S. 9-18: Shaping Digital Sustainable Development in Chemical Companies
17 (2020) 1, S. 20-40: Decarbonization Strategies in Converging Chemical and Energy Markets
17 (2020) 1, S. 41-57: Structuring and managing the new product development process – Review on th...
17 (2020) 1, S. 58-68: Application of Kuhn’s theory of scientific revolution to the theory develop...
17 (2020) 2, S. 70-82: Combine or combust? – Circular economy, digitalization and collaboration mo...
17 (2020) 2, S. 83-108: How to evaluate the future business potential of innovation fields in the ch...
17 (2020) 2, S. 109-130: Sustainability as a criterion for business models – A framework for the l...
17 (2020) 2, S. 131-150: Wealth effects of corporate spin-offs – An event study analysis of the ch...
17 (2020) 2, S. 151-190: User research in pharma R&D: Contextual inquiry for the elicitation of user...
17 (2020) 3, S. 1-16: Innovation and production management in the process industries — An extended...
17 (2020) 3, S. 17-31: Digital transformation in the Swedish process industries: Trends, challenges,...
17 (2020) 3, S. 32-58: Flawless start-up of production plants in process industries: The link betwee...
17 (2020) 3, S. 59-80: Success factors for intra-firm process technology transfer, and a petrochemic...
17 (2020) 3, S. 81-109: Supporting start-ups in the process industries with accelerator programs: Ty...
17 (2020) 3, S. 110-123: Start-ups as an indicator of early market convergence
18 (2021) 1, S. 2-8: Reducing the emissions Scope 1-3 in the chemical industry
18 (2021) 1, S. 9-19: The Strategic Approach to International Chemicals Management: A case study of ...
18 (2021) 1, S. 20-42: When data science meets patent information – Analyzing complex business env...
18 (2021) 2, S. 44-48: Sustainability in Uncertainty?
18 (2021) 2, S. 49-62: Validating the Product-Market-Fit of a B2B Platform Venture with a Minimum Vi...
18 (2021) 2, S. 63-78: Options for CO2-neutral production of bulk chemicals
18 (2021) 3, S. 80-95: Carbon Capture and Utilization – A new building block for Circular Economy?
18 (2021) 3, S. 96-104: Is the EU Green Deal channelling a transition towards a sustainable chemical...
18 (2021) 3, S. 105-108: Disruption of the role model closed loop mechanical recycling of PET
19 (2022) 1, S. 2-18: Joint Product Analysis of Rare Earths: Economic, Market and Technological Insi...
19 (2022) 1, S. 19-29: The Influence of Market Orientation on Innovativeness
19 (2022) 1, S. 30-35: Gender – an essential substance for sustainable chemistry
19 (2022) 1, S. 36-38: Better Batteries – Better Recycling?
19 (2022) 1, S. 39-43: My personal view on investment in chemistry start-ups
19 (2022) 2, S. 45-57: An exploration of the ankle-biters and their role in business ecosystems
19 (2022) 2, S. 58-72: Product footprint reporting for chemical companies
19 (2022) 2, S. 73-79: After COVID, What’s Next for Pharma Supply Chains?
19 (2022) 3, S. 81-99: Improvising in a crisis: an empirical study of NPD teams in the field of chem...
19 (2022) 3, S. 100-109: How chemicals can serve people sustainably without polluting the planet: th...
19 (2022) 3, S. 110-115: Cradle to Cradle: Why we need to rethink the way we produce
19 (2022) 3, S. 116-122: Current trends and challenges in the pharmaceutical industry – we are her...
20 (2023) 1, S. 9-30: Innovation methodologies and Design Thinking as supporting instruments in the ...
20 (2023) 1, S. 31-45: A review on influence factors promoting or inhibiting the transfer of researc...
20 (2023) 1, S. 46-59: The Northern Netherlands: Transformation of a gas-producing region into a for...
20 (2023) 1, S. 60-74: Ecosystem for Greentech start-ups in the Rhine-Main-Neckar metropolitan area ...
20 (2023) 2, S. 75-86: Transform the European process industries: A multi-level perspective
20 (2023) 2, S. 87-111: Exploring sustainability integration and expected outcomes of a digitalized ...
20 (2023) 2, S. 112-122: DATA – a sustainable performance accounting framework for SMEs. From macr...
20 (2023) 2, S. 123-128: The chemical industry as a key player for climate protection: Learning expe...
20 (2023) 2, S. 129-135: Sustainable industrial area management: Using the materiality analysis at a...
20 (2023) 2, S. 136-140: The role of hydrogen in the process industries – implications on energy i...
20 (2023) 2, S. 141-144: Responsible Use – The Social License-to-Operate A business approach towar...
20 (2023) 2, S. 145-150: Turning point(s) (“Zeitenwende”) and new multipolarity: Is the industry...
20 (2023) 2, S. 151-155: An active systemic industrial policy for climate-neutral process industries...
20 (2023) 3, S. 157-165: Building bridges in education: Exploring how engineering and MBA students c...
20 (2023) 3, S. 166-170: Intercultural leadership – A need for now and the future in chemical indu...
20 (2023) 3, S. 171-172: Book review – Chemistry Entrepreneurship
21 (2024) 1, S. 2-27: Structural analysis of petrochemical clusters in Germany: What can be learned ...
21 (2024) 1, S. 28-41: A catalyst for change? How sustainable finance can support the transition of ...
21 (2024) 1, S. 42-44: How to Enable the Transition From Fossil to Renewable Carbon in the Chemical ...

Patterns of collaboration along the bio-pharmaceutical innovation process

Ähnliche Einträge